Mutagenic potential of Mancozeb in Salmonella typhimurium

Yogeshwer Shukla1, Pankaj Taneja, Annu Arora

  • 1Environmental Carcinogenesis Division, Industrial Toxicology Research Centre, Lucknow, India. Yogeshwer_Shukla@hotmail.com

Insights

Mancozeb, a dithiocarbamate fungicide, showed toxicity to Salmonella typhimurium tester strains at high doses. Its potential mutagenicity may be masked by these toxic effects, limiting accurate assessment.

Area of Science:

  • Environmental toxicology
  • Microbial genetics
  • Chemical safety assessment

Background:

  • Dithiocarbamate fungicides are widely used in agriculture.
  • Assessing the mutagenic potential of pesticides is crucial for environmental and human health.
  • Mancozeb is a common fungicide requiring toxicological evaluation.

Purpose of the Study:

  • To investigate the mutagenic activity of Mancozeb using bacterial reverse mutation assays.
  • To determine if Mancozeb poses a genotoxic risk.

Main Methods:

  • Utilized Salmonella typhimurium tester strains (TA97a, TA98, TA100, TA102).
  • Administered Mancozeb at various concentrations.
  • Assessed mutagenic effects with and without metabolic activation.
  • Dissolved Mancozeb in DMSO or acetone.

Main Results:

  • Mancozeb exhibited toxicity at doses of 40 microg/plate and higher across all strains.
  • Strain TA97a showed dose-dependent increases in revertants, but less than twofold compared to controls.
  • Toxic effects potentially masked the true mutagenic potential.

Conclusions:

  • Mancozeb demonstrates significant toxicity to Salmonella typhimurium strains.
  • The fungicide's mutagenic potential may be underestimated due to its cytotoxic effects.
  • Further studies may be needed to elucidate Mancozeb's genotoxicity.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mismatch Repair01:36

Mismatch Repair

Overview
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...